Autoimmune R&D Data Characteristics
Autoimmune disease R&D documents primarily source data from clinical trial reports, pathological analyses, genomic data, proteomic data, and related scientific literature. These documents update frequently, especially during clinical trials, with data generated and revised in batches and phases. Document structures are complex, typically containing extensive unstructured text, tables, charts, and medical images. Text content involves specialized medical terminology, gene loci, protein names, drug molecular structures, dosage units (e.g., mg/kg), time units (e.g., days, weeks), and biomarker indicators. Tables often record patient baseline information, treatment plans, adverse events, and efficacy data.
Constraints from These Characteristics on Vector Models and Indexing
The complex structure and specialized terminology of autoimmune R&D documents demand high semantic understanding from vector models. Documents contain numerous synonyms, near-synonyms, and abbreviations, such as different gene naming conventions or cytokine family member expressions. This requires vector models to have stronger contextual understanding and entity recognition capabilities to avoid semantic drift. High update frequency necessitates an indexing system that supports efficient incremental updates and real-time queries, ensuring researchers access the latest developments. Numerical data, units, and time information in documents, such as 10 mg/kg or 12 weeks of treatment, are crucial for disease progression and drug efficacy. The vector index must accurately identify and associate these with relevant context during recall, avoiding reliance solely on text similarity that overlooks numerical or unit accuracy. The large volume of documents and sensitive information also challenge index security, permission management, and retrieval efficiency.
Configuration Guidelines
| Configuration Item | Recommended Approach | Rationale |
|---|---|---|
Chunk Length | 500–800 characters | Balances semantic completeness and vectorization efficiency. Avoids noise from overly long chunks and context loss from overly short ones. |
Chunk Overlap Length | 50–100 characters | Ensures semantic continuity between chunks. Prevents critical information from being split at chunk boundaries. |
Vector Model | Calibrate based on actual measurements | Requires fine-tuning on specialized autoimmune corpora or selecting a pre-trained model to enhance terminology understanding. |
Recall Count | 10–20 items | Balances recall rate with computational resource consumption. Provides sufficient candidates for subsequent re-ranking. |
Similarity Threshold | Calibrate based on actual measurements | Requires practical query testing to balance recall and precision, typically between 0.7–0.85. |
Re-ranked Return Count | 3–5 items | Focuses on the most relevant results for the user, reducing information overload. |
Common Pitfalls
- Symptom: FastGPT calls to the Ollama vector model are rejected, but
curltests pass. Reason: The Ollama service may have authentication or network policy restrictions preventing FastGPT's internal requests, whilecurlrequests might use different network paths or authentication methods. - Symptom: Significant duplicate content appears after knowledge base index merging. Reason: The default deduplication strategy of the index merging component is insufficient to identify common variant expressions or different versions of the same experimental data in autoimmune documents.
- Symptom: Queries about specific gene loci or drug dosages yield inaccurate results or miss critical numerical information. Reason: The vector model's training inadequately recognizes numerical values, units, and specialized entities, leading to failure in effectively encoding this key information during vectorization.
Configuration Validation
- Select a batch of autoimmune test documents containing specific genes, drug dosages, and clinical indicators. Upload and index them, then check if they are correctly parsed and vectorized.
- Use query statements with specialized terminology, such as "efficacy of IL-6 inhibitors in rheumatoid arthritis." Check if the recalled document snippets accurately contain relevant entities and context, and evaluate if the recall count matches expectations.
- Perform an incremental update on the index by uploading a small amount of new clinical trial data. Then, perform queries to verify that the new data is promptly indexed and correctly recalled.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.